Monthly Archives

January 2019

2019 Annual Health Summit & Legislative Day

  • January 30, 2019
  • admin

Join Family Voices of California at the 2019 Annual Health Summit & Legislative Day, on March 10-12, 2019, to hear from experts and... Continue Reading

Emmaus Life Sciences Launches Its Commercial Co-Payment Assistance Program for Endari™

  • January 28, 2019
  • admin

TORRANCE, Calif., Jan. 28, 2019 /PRNewswire/ — Emmaus Life Sciences, Inc. (Emmaus), a leader in sickle cell disease treatment, announced today that... Continue Reading

WEBINAR TODAY: Introducing the Blueprint for Complex Care: Opportunities to Advance the Field

  • January 22, 2019
  • admin

Introducing the Blueprint for Complex Care: Opportunities to Advance the Field WEBINAR Date: January 22, 2019 Time: 2:00 pm- 3:00 pm... Continue Reading

ASGCT Society Patient Education Program

  • January 18, 2019
  • admin

The American Society of Gene & Cell Therapy (ASGCT) is proud to announce the first release of the Society’s Patient Education program, a new initiative... Continue Reading

47th Annual National Convention Call for Abstracts

  • January 18, 2019
  • admin

If you are you a researcher, community-based member organization, physician, nurse, social worker or someone working on behalf of people with... Continue Reading

47th Annual National Convention Theme Announced

  • January 18, 2019
  • admin

Sickle Cell Disease Association of America, Inc. is pleased to announce the theme for the 47th Annual National Convention: Sickle Cell Community... Continue Reading

SCDAA Hires New Director of Development & Special Initiatives

  • January 9, 2019
  • admin

Baltimore City native, Gary Bonner, will serve as the Director of Development & Special Initiatives. In this capacity, Bonner will oversee SCDAA’s national... Continue Reading

SCDAA Hires New Care Coordinator

  • January 9, 2019
  • admin

Tiffany Scott will serve as SCDAA’s Care Coordinator for the Health Resources Services Administration (HRSA) grant-funded Newborn Screening Follow-up Program. In... Continue Reading

CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease

  • January 4, 2019
  • admin

CRISPR Therapeutics and Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation... Continue Reading